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Box 1. Key questions 
• What is angiosomal revascularisation? 
• What literature is available to support decision making when 
performing endovascular or open tibial artery revascularisation? 
• What arteries should we actually target during clinical practice to get 
the best outcomes for the patient? 
 
Angiosome specific revascularisation, does the evidence support it? The 
answer is actually yes and no, depending on the arteries available and 
whether you accept the findings of the literature as it stands. The evidence to 
support clinical decision making does exist, but the highest quality papers are 
meta-analyses limited by the fact that they can only include low quality cohort 
studies.1,2 Because of this, the strength of recommendations that can be 
made are low, and the results based on procedures involving logical selection 
bias.  
This educational review aims to discuss the main issues around clinical 
decision making for angiosome-directed revascularisation via a clinical 
vignette which would be seen commonly in clinical practice.  
 
Angiosomes 
The angiosome concept was first described in 1987, defining an angiosome 
as an area of tissue comprising skin, subcutaneous tissue, fascia, muscle, 
and bone supplied by a specific artery and drained by a specific vein (Figure 
1).3 It was initially defined by plastic surgeons, so the anatomical assumptions 
were based on healthy vessels, rather then those diseased enough to require 
intervention.4 
In the most common angiosome model the foot consists of six 
angiosomes; three arising from the posterior tibial artery, two from the 
peroneal artery, and one from the anterior tibial artery (Figure 1). Patients with 
critical limb ischaemia who develop tissue loss in a specific angiosome(s) and 
undergo tibial artery revascularisation are considered to have a 'direct 
reperfusion' (DR) when the artery of interest supplies the area of tissue loss, 
and 'indirect reperfusion' (IR) when it does not. This is most commonly 
defined in the literature using the Taylor and Palmer model.4 As an example, 
the most common form of direct reperfusion for tissue loss in the tips of the 
toes would be via the anterior tibial artery, and indirect reperfusion via the 
peroneal artery.  
Several other angiosome models have been suggested, and 
importantly, the changes in the foot vessels in peripheral vascular disease, 
especially diabetes, may alter this strict angiosomal perfusion pathway. This 
may confuse direct reperfusion between the anterior and posterior tibial 
arteries, or lead to a theoretically direct reperfusion (from the normal 
anatomical model described by plastic surgeons), such as an anterior tibial 
angioplasty, not actually reperfusing the area of interest because there are no 
distal vessels supplying the tissue loss.5 
 
Clinical scenario 
A 58 year old man presented with tissue loss to the tips of the first and second 
toes of the left foot (see Figure 2, patient consent provided). He was a 
smoker, and was diagnosed as diabetic when he presented acutely four 
months earlier with severe foot sepsis of the right foot and leg. When he 
presented, he was on Aspirin 75mg but no lipid lowering therapy. Atorvastatin 
40mg was added on presentation to hospital. Despite treatment this leg was 
amputated due to a combination of non-reconstructable disease and 
extensive tissue loss. The left foot was asymptomatic at that time with a plan 
for diabetic foot clinic follow up. He did not attend these appointments until he 
was forced to by the artificial limb centre because of new tissue loss in his left 
foot. At that point he had palpable femoral and popliteal pulses, with 
incompressible calf vessels, a toe-brachial index of 0.3 and an absolute toe 
pressure of 38mmHg. Sensation was lost below the level of the ankle.  
 CT angiography showed essentially normal arteries to the knee with 
severe tibial disease and no obvious target artery in the foot. After 
multidisciplinary team discussion he underwent tibial angioplasty. A 4 French 
sheath was inserted into the common femoral artery under ultrasound 
guidance. Digital subtraction angiography from this showed good flow to the 
trifurcation with three vessel tibial disease. The anterior tibial artery appeared 
to be occluded near the origin as was the posterior tibial. The peroneal was 
stenosed at origin but appeared the best vessel. Because both CT 
angiography and digital subtraction angiography from a common femoral 
sheath can miss target vessels in the foot, selective angiography through a 4 
french catheter was performed from the popliteal trifurcation (see Figure 3). 
Delayed phase imaging showed that the anterior tibial was patent to the mid 
calf but occluded distally with reconstitution of the dorsalis pedis in the foot. 
The plantar arch was heavily diseased and likely occluded.  
The operator chose to try and reconstitute the anterior tibial artery as 
this would provide direct reperfusion of the angiosome affected. Re-entry at 
the dorsalis pedis failed (Figure 4). The peroneal artery was therefore treated 
successfully (Figure 5).  
The post-procedural toe-brachial index was 0.45 with an absolute 
pressure of 63mmHg. The increase in perfusion pressure was sustained and 
medical therapy optimised. He was treated in a total contact cast. The wounds 
would not fully heal after several months despite a sustained increase in toe-
brachial index. He continued to miss outpatient appointments and ultimately 
re-presented with severe infected tissue loss requiring major amputation. 
In this case, direct reperfusion of the toes via the dorsalis pedis 
angiosome was attempted but failed; so indirect reperfusion was achieved via 
the peroneal artery. Are the clinical results what we would expect based on 
the literature? 
 
The evidence for angiosome specific revascularisation 
As already mentioned, the literature is very low quality. In terms of comparing 
direct and indirect revascularisation outcomes, meta-analysis offers the best 
way to summarise findings.1,6 There are no randomised trials, and the cohort 
studies available for meta-analysis have a median Newcastle Ottawa score (a 
marker of study quality marked from 0 to 9) of 5, so moderate quality.  
GRADE analysis (which gives the strength of recommendation for an 
individual outcome from meta-analysis) is low or very low for all outcomes, 
meaning there is only a low quality or certainty to the results discussed.6 
With this in mind, for both endovascular and open surgery, direct 
angiosomal reperfusion is superior to indirect reperfusion for wound healing 
(Table 1: Odds ratio (OR) 0.51 (0.39 - 0.68), p<0.00001) and limb salvage 
(OR 0.37 (0.24 - 0.58), p<0.0001). Although the effect size is marginally 
stronger for open surgery, the difference between direct and indirect 
revascularisation is more pronounced for endovascular intervention. All case 
series inherently contain selection bias, and the majority of the endovascular 
selection bias (direct fails so indirect becomes the default) is highlighted by 
the clinical case presented.  
 
Endovascular clinical context 
The clinical scenario presented is an example of indirect peroneal angiosomal 
reperfusion of the toes. The patient had a poor outcome in terms of wound 
healing, then eventually lost the leg despite a presumably patent angioplasty 
site based on sustained improvements in pressure readings. This fits with the 
findings in the literature, but more importantly, highlights the essential problem 
with its selection bias; this man could only have an indirect reperfusion 
because there were no target arteries in the foot. His outcome was therefore 
always likely to be worse than a patient with a patent foot vessel, who usually 
has a direct angioplasty or bypass option. If the dorsalis pedis had been very 
good in this man we could have tried a repeat angioplasty, possibly via a 
retrograde dorsalis pedis puncture, or offered him open bypass (or entry into 
the BASIL 2 randomised trial7). The presence of a useable dorsalis pedis 
would have moved him from the indirect to direct group and he may have 
fared better, all because of the good runoff vessel rather than an active choice 
between direct or indirect reperfusion.  
 When tibial angioplasty was first performed there was a trend towards 
preserving the best tibial vessel and treating the easy or ‘safe’ vessel (usually 
the peroneal) leaving the best vessel for bypass if the angioplasty failed. This 
approach is doomed to failure, and such selection bias may contribute to the 
results in Table 1, because indirect reperfusion leads to worse outcomes. This 
is where a balanced decision making process between endovascular and 
open surgery is so important, because while tibial angioplasty is suitable for 
the majority of these patients, a strict endovascular first policy may lead to 
worse outcomes in patients needing open surgery after attempted 
endovascular intervention.7 
 
Combined revascularisation 
Another concept for tibial revascularisation is combined revascularisation, i.e. 
performing direct and indirect revascularisation at the same time. There is 
little evidence in this area: two case series and a small randomised trial.5,8,9 
The results from both endovascular series are the same, so the results 
presented here are from our unit.5 
 Essentially, if you can open more than one tibial vessel during tibial 
angioplasty the results for amputation free survival are better (Adjusted 
Hazard Ratio 0.504, p=0.039, Figure 6).5 The results from combined 
angioplasty were, however, no better than direct, but were significantly better 
than indirect after adjusting for confounders. The numbers are low in this 
series (250 total, only 22 in the combined revascularisation group) and there 
is inherent selection bias for the same reasons as the clinical case presented; 
if the patient has the potential to open more than one tibial vessel it is likely 
that they have better runoff. It nevertheless represents the only confounder-
adjusted series on combined endovascular reperfusion in the literature.  
 A randomised trial comparing endovascular treatment of one tibial 
vessel with more than one tibial vessel has been published recently.8 The set-
up was subtly different from comparing combined vs. direct or indirect 
because the angiosome wasn’t considered, just the technical ability to open 
multiple vessels. The foot arch had to be patent for inclusion. However, the 
results are likely to be biased because there were significantly more direct 
reperfusions in the group having multiple vessels treated (75% vs. 40% p= 
0.004). There appeared to be no difference when pure angiosomal 
revascularisation was examined but the numbers in the trial were too small to 
accurately adjust for major confounders like this. We can therefore choose 
whichever story fits our own confirmation bias to explain the results, if we 
accept that they are accurate. Either direct reperfusion (here more than one 
tibial vessel) was better than indirect (single vessel), or, supply more 
oxygenated blood to the ischaemic area by opening multiple tibial vessels and 
get a better result (more on that in the ‘Breakdown of the classic angiosome 
model’ section).  The aforementioned case series’ suggest that combined 
reperfusion (direct and indirect) was no better than direct alone, but the 
reported results of the trial did not examine this specifically.   
 
Open surgery clinical context 
Open surgical bypass is worth considering separately because the outcomes 
are slightly different to the endovascular group. The significance between 
direct and indirect reperfusion is lost for wound healing, and diminished for 
limb salvage and mortality when comparing direct and indirect 
revascularisation (Table 1).  
 Again, in the cohort literature there is selection bias because the 
majority of (now historical) studies with large patient numbers included in 
meta-analysis offered a bypass first approach for excellent run off and the 
presence of a vein for conduit.1,6 In open surgery the old adage of “restoring 
in-line flow” to the area has always been followed because it seems to be 
common sense. And common sense prevails here because a direct open 
operation is superior to an indirect; although how many surgeons would 
bypass to a peroneal artery if a posterior or anterior tibial with flow into the 
foot were available for tissue loss in the foot? Selection bias will again be rife.  
 Accurately comparing open and endovascular intervention for 
angiosome specific outcomes is impossible from the literature. The 
comparative results of open and endovascular tibial revascularisation have, 
however, been contentious enough for the BASIL 2 randomised trial of 
endovascular first vs. open first approach to tibial intervention to exist and to 
currently be recruiting.10  
 
Breakdown of the classic angiosome model and other concepts 
Back to the clinical case above and Figure 3b – the angiosome model is not 
neatly applicable to this man’s foot. Even if ‘direct’ reperfusion via the anterior 
tibial was possible, he has no named vessels in his foot supplying the toes, so 
revascularisation would not be truly direct. This happens commonly in 
diabetes but it’s unclear how important it is when comparing direct and 
indirect outcomes.  
 The ‘functional angiosome’ is the body’s response to adapt to 
ischaemia and has mainly been defined through animal studies.11 This is 
when natural interconnections, or choke vessels, between major, named 
arteries (usually in the foot) dilate in response to ischaemia. While there is no 
standardised definition, a collateral is the end result of permanent dilation of a 
choke vessel in response to ischaemia.  
 This is where imaging studies help clinical decision-making. In a recent 
series of 120 peroneal bypasses, the patency of the foot arch was more 
important for a good outcome than looking at the ‘classic’ angiosome location 
of the wound.12 So we’re back to inline flow, even if it’s not ‘direct’ in the 
traditional sense; if the peroneal collateralises into the foot arch as a 
functional angiosome, to the extent that a distal bypass will run, the patient 
will do well. However this isn’t the whole picture because even in angioplasty, 
which may be successful with no foot arch, direct reperfusion is superior to 
indirect in diabetic patients with almost no foot vessels remaining.13  
 Perfusion studies tend to show global increases in foot perfusion after 
tibial reperfusion, whether direct or indirect, with no specific differences in 
diabetic patients.14,15 These studies also tend to show a non-angiosomal 
pattern of ischaemia and reperfusion in critical ischaemia, although they are 
small series which did not examine this specifically. This implies that it might 
be most important to supply a greater volume of oxygenated blood to the foot 
by whatever means, and that because a direct reperfusion is more likely to 
involve a patient with a patent foot vessel or arch, they fare better after 
intervention. This also leads to the theory that patients undergoing indirect 
open bypass may do better than the same patient undergoing indirect 
endovascular intervention, because the bypass provides a greater volume of 
blood. There are counter arguments to this: tibial angioplasty only needs to 
work long enough to heal the wound and can be repeated; the leg is less 
likely to be lost if a tibial angioplasty occludes than if a bypass occludes etc. 
but all of the arguments for and against are essentially cognitive bias because 
they are based on inconclusive data.   
  
Summary  
So does the evidence support angiosome specific revascularisation? Yes, in 
the limited way that it is able to, as it supports the common sense notion of 
restoring in-line flow to the area of ischemia for the best outcomes. No, in that 
if you stick rigidly to the old Taylor and Palmer model you’ll get caught out 
because what we actually call an angiosome in disease states is debatable. 
Perfusion studies show that maximising perfusion is key, and this might be via 
an indirect peroneal reperfusion if this collateralises significantly into the foot 
arch. Indirect reperfusion without a good vessel leading to the ischaemic area 
may be technically successful as in the case scenario, but will lead to worse 
outcomes because it is a great example of selection bias in clinical practice 
and for this reason it is a useful prognostic indicator. Further randomised trials 
in this area would add little and are potentially harmful, because although the 
existing literature is biased it can still guide us to the right strategy: target the 
best vessels with runoff leading to the ischaemic tissue. 
  
 
 
 
 
Box 2. Take home messages. 
• An angiosome is an area of tissue comprising skin, subcutaneous 
tissue, fascia, muscle, and bone supplied by a specific artery and 
drained by a specific vein. It was defined in healthy subjects.  
• The angiosome literature for peripheral vascular intervention is low 
quality and clearly contains bias. 
• The ‘classic’ angiosome model may not apply to patients with 
peripheral vascular disease, especially diabetics. 
• Reperfusion via the artery leading directly to the area of tissue 
ischaemia is more important than sticking to the ‘classic’ angiosome 
model.  
• If feasible, opening multiple arteries endovascularly may be useful so 
long as at least one provides supply directly to the ischaemic area. 
• The angiosome model appears less relevant in open surgery than 
endovascular intervention.   
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Table 1. Summary of meta-analysis findings for direct versus indirect 
angiosomal revascularisation. HG=heterogeneity. CI=confidence interval. 
Modified from Dilaver et al5 
 
No. of 
studies 
(total 
limbs) 
Direct 
(n) 
Indirect 
(n) 
HG I2 
(%) 
HG p-
value OR (95% CI) 
Overall 
effect 
Z p-value 
Wound healing          
All studies 18 (2998) 1557 1441 56 0.002 0.51 (0.39 - 0.68) 4.57 < 0.00001 
Endovascular  11 (2174) 1147 1027 61 0.004 0.48 (0.34 - 0.67) 4.30 < 0.0001 
Open bypass  8 (865) 482 383 48 0.06 0.64 (0.39 - 1.07) 1.71 0.09 
Limb salvage          
All studies 20 (3144) 1613 1531 73 < 0.00001 0.37 (0.24 - 0.58) 4.36 < 0.0001 
Endovascular  12 (2243) 1158 1085 81 < 0.00001 0.36 (0.20 - 0.66) 3.30 0.001 
Open bypass  8 (866) 482 384 33 0.17 0.56 (0.33 - 0.94) 2.18 0.03 
Mortality          
All studies 9 (1213) 641 572 56 0.02 0.73 (0.45 - 1.18) 1.29 0.2 
Endovascular 3 (303) 151 152 0 0.54 1.16 (0.69 - 1.96) 0.57 0.57 
Open bypass 3 (237) 138 99 0 0.61 0.35 (0.16 - 0.78) 2.59 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The most common angiosome model of the leg and foot. 
Reproduced from Iida et al.3 
 
Figure 2. Pattern of tissue loss. 
 
Figure 3. Selective digital subtraction angiography from the popliteal artery, 
left leg. (a). Anteroposteior view below knee, (b). Lateral view foot. (a) Inflow 
shows a moderate popliteal stenosis. (a) The anterior tibial has a stenosis at 
origin with mid vessel occlusion, (b) and some reconstitution of the dorsalis 
pedis in the foot. (a) Peroneal origin stenosis with moderate multilevel 
disease, (b) the peroneal is then the best vessel at the ankle but with minimal 
collateralisation into the foot. (a) Severe posterior tibial artery disease from 
origin, (b) it occludes above the ankle with no foot arch reconstitution.  
 
Figure 4. Failed re-entry into dorsalis pedis. 
 
Figure 5. Post angioplasty angiography. The popliteal and peroneal have 
been successfully treated by plain balloon angioplasty. (a). The peroneal is 
now filling preferentially. (b). The distal peroneal also fills preferentially. The 
short remaining dorsalis pedis does still fill as it did pre-procedure on late 
angiography, but the foot arch still appears absent (c). 
 
Figure 6.  Kaplan-Meier graph comparing amputation-free survival in patients 
undergoing combined approach angioplasty versus the indirect and direct 
approaches. Adjusted Hazard Ratio 0.492, p = 0.082 for combined versus 
direct, adjusted Hazard Ratio 0.426, p = 0.037 for combined versus indirect. 
Reproduced from Ambler et al.4 
 
